A Vasků et al.
Casopis lekaru ceskych, 139(15), 464-467 (2000-08-02)
Identification of mutations contributing to the pathogenesis of essential hypertension performs to understand deeper consequences of developing pathophysiological changes, to value individual risk of hypertension in the preclinical stages and, regarding the observed genotype, to choose optimum therapy. The aim